CIPARS: Antimicrobial Resistance:

CIPARS interactive data visualization for AMR findings by:

• Antimicrobial or grouping (for example: multi-class resistance)
• Surveillance component (for example: farm, abattoir, retail)
• Bacterial genus (for example: Salmonella)
• Host species

For additional information, please visit the Public Health Agency of Canada’s Canadian Integrated Program for Antimicrobial Resistance Surveillance (CIPARS).

* Subtype data is coming soon.

---

Figure 1. Temporal trends in Canada of ceftriaxone-resistant Escherichia coli or Salmonella* isolates, and ceftiofur use in broiler chicken flocks.

Displaying AMU and AMR data together does not imply causation

Hover over the line graph to see more details on the temporal trends in Canada of ceftriaxone-resistant Escherichia coli or Salmonella* isolates, and ceftiofur use in broiler chicken flocks. Click on a legend element to add or remove the corresponding lines from the graph.

Notes

• * Human data: aggregated non-typhoidal and typhoidal strains reported. No typhoidal strains have been identified in the other components.
• All data shown are unadjusted for clustering.
Retail data: includes chicken (raw chicken, for example: breasts, thighs and wings), ground beef, and pork isolates from both CIPARS and FoodNet Canada, as well as turkey from CIPARS.
• Prairies region may include one or more provinces, including Alberta, Manitoba and Saskatchewan
• The COVID-19 Pandemic resulted in several disruptions to CIPARS surveillance activities in 2020 and 2021.

Table 1. Temporal variation in percentage of ceftriaxone-resistant Escherichia coli or Salmonella isolates, by surveillance component, in Canada.

Figure 1: Text description

Year	Percentage of isolates resistant to ceftriaxone by surveillance component

Temporal variation of ceftiofur use (% flocks) in Canada

Year	Percent of broiler chicken flocks reporting ceftiofur use

---

Figure 2. Temporal trends in Canada of antimicrobial-resistant Escherichia coli or Salmonella* isolates.

Hover over the line graph to see more details on the temporal trends in Canada of antimicrobial-resistant Escherichia coli or Salmonella* isolates. Click on a legend element to add or remove the corresponding lines from the graph.

Notes

• * Human data: aggregated non-typhoidal and typhoidal strains reported. No typhoidal strains have been identified in the other components.
• All data shown are unadjusted for clustering.
Retail data: includes chicken (raw chicken, for example: breasts, thighs and wings), ground beef, and pork isolates from both CIPARS and FoodNet Canada, as well as turkey from CIPARS.
• Prairies region may include one or more provinces, including Alberta, Manitoba and Saskatchewan
• The COVID-19 Pandemic resulted in several disruptions to CIPARS surveillance activities in 2020 and 2021.

Table 2. Temporal trends in percentage of antimicrobial-resistant Escherichia coli or Salmonella isolates, by surveillance component and host species, and region, in Canada.

Figure 2: Text description

Year	Percentage of isolates resistant by surveillance component

---

Figure 3. Temporal trends in Canada of multiclass-resistant Escherichia coli or Salmonella* isolates.

Hover over the line graph to see more details on the temporal trends in Canada of multiclass-resistant Escherichia coli or Salmonella* isolates. Click on a legend element to add or remove the corresponding lines from the graph.

Notes

• Resistant to 3 or more classes: Isolates were resistant to 3, 4, 5, 6 or 7 antimicrobial classes.
• Resistant to 5 or more classes: Isolates were resistant to 5, 6 or 7 antimicrobial classes.
• Retail data: includes chicken (raw chicken, for example: breasts, thighs and wings), ground beef, and pork isolates from both CIPARS and FoodNet Canada, as well as turkey from CIPARS.
• Prairies region may include one or more provinces, including Alberta, Manitoba and Saskatchewan
• The COVID-19 Pandemic resulted in several disruptions to CIPARS surveillance activities in 2020 and 2021.

Table 3. Temporal trends in percentage of multiclass resistance outcomes among Escherichia coli or Salmonella isolates, by surveillance component and host species, in Canada.

Figure 3: Text description

Year

---